heiBIB: Saußele, Susanne

Saußele, Susanne Dr. med.Universität HeidelbergHeidelberg

Refine publication list

Year of publication

Type of Publication

List

Language

English (108)
German (9)

Co-author (Univ. of Heidelberg)

more ...

Co-author (external)

more ...

Publications in heiBIB

Pfirrmann, Markus: How to interpret the EURO-SKI study and its treatment-free remission outcome : reply to R.P. Gale and J. Chen : correspondence / Markus Pfirrmann, Susanne Saussele, François-Xavier Mahon, Johan Richter, 03 January 2024. - 3 S.
In: Leukemia, ISSN 1476-5551. 38(2024), 2, Seite 460-462
DOI: 10.1038/s41375-023-02124-3
Hirschinger, Hanna: Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam : study protocol for a randomised controlled open-label monocentric trial (MinTU Study) / Hanna Hirschinger, Evelyn Jaeger, Stefanie Nittka, Svetlana Hetjens, Christine Lorenz, Constanze Rem… , 03 January 2024. - 7 S.
In: BMC palliative care, ISSN 1472-684X. 23(2024), 1, Seite 1-7
DOI: 10.1186/s12904-023-01330-1
Efficace, Fabio: Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors : results from the EURO-SKI Trial / Fabio Efficace, Francois-Xavier Mahon, Johan Richter, Alfonso Piciocchi, Marta Cipriani, Franck E. N… , August 2024. - 9 S.
In: Leukemia, ISSN 1476-5551. 38(2024), 8 vom: Aug., Seite 1722-1730
DOI: 10.1038/s41375-024-02341-4
Mahon, François-Xavier: European Stop Tyrosine Kinase Inhibitor trial (EURO-SKI) in chronic myeloid leukemia : Final analysis and novel prognostic factors for treatment-free remission / Francois-Xavier Mahon, MD, PhD; Markus Pfirrmann, PhD; Stéphanie Dulucq, PhD; Andreas Hochhaus, MD, … , June 1, 2024. - 11 S. : Illustrationen
In: Journal of clinical oncology, ISSN 1527-7755. 42(2024), 16, Seite 1875-1880
DOI: 10.1200/JCO.23.01647
Brioli, Annamaria: Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry / Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksa… , May 2024. - 9 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 38(2024), 5, Seite 1072-1080
DOI: 10.1038/s41375-024-02204-y
Kockerols, Camille: Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients / Camille Kockerols, Peter J.M. Valk, Jeroen J.W.M. Janssen, Pauline Hogenbirk, Jan J. Cornelissen, Su… , November 2024. - 8 S. : Illustrationen
In: European journal of haematology, ISSN 1600-0609. 113(2024), 5, Seite 606-613
DOI: 10.1111/ejh.14271
Flygt, Hjalmar: Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial : correction / Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Sat… , April 2024. - 1 S.
In: Leukemia, ISSN 1476-5551. 38(2024), 4 vom: Apr., Seite 925-925
DOI: 10.1038/s41375-024-02184-z
Flygt, Hjalmar: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial : chronic myelogenous leukemia / Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Sat… , April 2024. - 7 S.
In: Leukemia, ISSN 1476-5551. 38(2024), 4 vom: Apr., Seite 781-787
DOI: 10.1038/s41375-024-02145-6
Machova Polakova, Katerina: The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib : article / Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola … , 2024. - 8 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 38(2024), 2, Seite 318-325
DOI: 10.1038/s41375-023-02109-2
Hochhaus, Andreas: Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors : longer-term follow-up of ASCEMBL / Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E. Cortes, Timothy P. Hughes,… , March 2023. - 10 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 37(2023), 3, Seite 617-626
DOI: 10.1038/s41375-023-01829-9
Isfort, Susanne: Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy : results of the Bosutinib Dose Optimization (BODO) Study / Susanne Isfort, Kirsi Manz, Lino L. Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus,… , October 2023. - 12 S. : Illustrationen
In: Annals of hematology, ISSN 1432-0584. 102(2023), 10, Seite 2741-2752
DOI: 10.1007/s00277-023-05394-0
Westphalen, Christoph Benedikt: Therapiesteuerung in der Hämatologie und Onkologie / C. Benedikt Westphalen, Bernd J. Krause, Markus Schuler, Sara Y. Brucker, Andreas Hartkopf, Leo Rasc… , September 2023. - 25 S. : Illustrationen
In: Oncology research and treatment, ISSN 2296-5262. 46(2023), 4 vom: Sept., Seite 2-26
DOI: 10.1159/000533463
Saußele, Susanne: Addendum to the German consensus recommendations on ponatinib in the treatment of chronic myeloid leukemia : review / Susanne Saussele, Paul La Rosée, Alexander Kiani, Wilhelm Haverkamp, Kathleen Jentsch-Ullrich, Frank… , October 17, 2023. - 8 S. : Illustrationen
In: Acta haematologica, ISSN 1421-9662. (2023), Seite 1-8
DOI: 10.1159/000533666
Shah, Neil P.: Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response : final 5-year analysis of DASFREE: original paper / Neil P. Shah, Valentín García-Gutiérrez, Antonio Jiménez-Velasco, Sarah M. Larson, Susanne Saussele,… , September 2023 : Illustrationen
In: British journal of haematology, ISSN 1365-2141. 202(2023), 5 vom: Sept., Seite 942-952
DOI: 10.1111/bjh.18883
Zambrotta, Giovanni Paolo Maria: Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation : final analysis of the TFR-PRO study / Giovanni Paolo Maria Zambrotta, Franck E. Nicolini, Sarit Assouline, Lambert Busque, Ester Pungolino… , November 2023. - 10 S. : Illustrationen
In: American journal of hematology, ISSN 1096-8652. 98(2023), 11 vom: Nov., Seite 1762-1771
DOI: 10.1002/ajh.27073
Lauseker, Michael: Survival with chronic myeloid leukaemia after failing milestones / Michael Lauseker, Rüdiger Hehlmann, Andreas Hochhaus and Susanne Saußele, 19 September 2023. - 6 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 37(2023), 11, Seite 2231-2236
DOI: 10.1038/s41375-023-02028-2
Spiess, Birgit: Reverse transcription can critically impact the diagnostic outcome of BCR::ABL1 quantitative real-time RT-PCR / Birgit Spiess, Helga Kleiner, Irina Tarnopolscaia, Nicole Naumann, Alice Fabarius, Wolf-Karsten Hofm… , 2023. - 18 S.
In: Cancers, ISSN 2072-6694. 15(2023), 15, Artikel-ID 3914, Seite 1-18
DOI: 10.3390/cancers15153914
Christiani, Eva: Gene expression pattern of ESPL1, PTTG1 and PTTG1IP can potentially predict response to TKI first-line treatment of patients with newly diagnosed CML / Eva Christiani, Nicole Naumann, Christel Weiss, Birgit Spiess, Helga Kleiner, Alice Fabarius, Wolf-K… , 8 May 2023. - 17 S.
In: Cancers, ISSN 2072-6694. 15(2023), 9 vom: Mai, Artikel-ID 2652, Seite 1-17
DOI: 10.3390/cancers15092652
Saußele, Susanne: Incidence, prevalence, and real-world treatment patterns in chronic myeloid leukemia : results from a population-representative German claims data analysis / Susanne Saußele, Katharina Kohlbrenner, Tobias Vogelmann, Tino Schubert, August 2022. - 7 S.
In: Oncology research and treatment, ISSN 2296-5262. 45(2022), 7-8 vom: Aug., Seite 400-406
DOI: 10.1159/000524284
White, Helen: Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study : chronic myologenous leukemia / Helen E. White, Matthew Salmon, Francesco Albano, Christina Søs Auður Andersen, Stefan Balabanov, Gu… , 25 May 2022. - 9 S.
In: Leukemia, ISSN 1476-5551. 36(2022), 7, Seite 1834-1842
DOI: 10.1038/s41375-022-01607-z
Rotterdam, Jil: Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases / Jil Rotterdam, Margot Thiaucourt, Christel Weiss, Juliana Schwaab, Andreas Reiter, Sebastian Kreil, … , 21 May 2022. - 10 S.
In: Annals of hematology, ISSN 1432-0584. 101(2022), 8 vom: Aug., Seite 1825-1834
DOI: 10.1007/s00277-022-04866-z
Schönfeld, Lioba: ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia / Lioba Schönfeld, Jenny Rinke, Anna Hinze, Saskia N. Nagel, Vivien Schäfer, Thomas Schenk, Christian … , 28 July 2022. - 8 S.
In: Leukemia, ISSN 1476-5551. 36(2022), 9, Seite 2242-2249
DOI: 10.1038/s41375-022-01648-4
Hehlmann, Rüdiger: Impact of emerging ACA on survival in chronic myeloid leukemia (CML) : chronic myelogenous leukemia : correspondence / Rüdiger Hehlmann, Michael Lauseker, Astghik Voskanyan, Alice Fabarius, Claudia Haferlach, Andreas Ho… , 23 August 2022. - 4 S.
In: Leukemia, ISSN 1476-5551. 36(2022), 10, Seite 2544-2547
DOI: 10.1038/s41375-022-01681-3
Hehlmann, Rüdiger: High-risk additional chromosomal abnormalities at low blast counts herald death by CML / Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, Markus Pfirrmann, Lida Kalmanti, Sebastien Ri… , 07 May 2020. - 13 S.
In: Leukemia, ISSN 1476-5551. 34(2020), 8, Seite 2074-2086
DOI: 10.1038/s41375-020-0826-9
Spiess, Birgit: Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients / Birgit Spiess, Helga Kleiner, Johanna Flach, Alice Fabarius, Susanne Saussele, Wolf-Karsten Hofmann,… , 06 April 2020. - 16 S.
In: Annals of hematology, ISSN 1432-0584. 99(2020), 5, Seite 991-1006
DOI: 10.1007/s00277-020-04007-4
Efficace, Fabio: Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia / Fabio Efficace, Alessandra Iurlo, Andrea Patriarca, Fabio Stagno, Ping-Chong Bee, Geneviève Ector, I… , 2021. - 10 S.
In: Leukemia and lymphoma, ISSN 1029-2403. 62(2021), 3, Seite 669-678
DOI: 10.1080/10428194.2020.1838509
Popp, Henning: DNA damage and DNA damage response in chronic myeloid leukemia / Henning D. Popp, Vanessa Kohl, Nicole Naumann, Johanna Flach, Susanne Brendel, Helga Kleiner, Christ… , 11 February 2020. - 12 S.
In: International journal of molecular sciences, ISSN 1422-0067. 21(2020,4) Artikel-Nummer 1177, 12 Seiten
DOI: 10.3390/ijms21041177
Möbius, Susanne: Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry) / Susanne Möbius, Thomas Schenk, Danny Himsel, Jacqueline Maier, Georg-Nikolaus Franke, Susanne Sausse… , 2 April 2019. - 6 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 145(2019), 6, Seite 1645-1650
DOI: 10.1007/s00432-019-02910-6
Michel, Christian: Imatinib dose reduction in major molecular response of chronic myeloid leukemia : results from the German Chronic Myeloid Leukemia-Study IV / Christian Michel, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Andreas Neubauer, Michael La… , 2019. - 8 S.
In: Haematologica, ISSN 1592-8721. 104(2019), 5, Seite 955-962
DOI: 10.3324/haematol.2018.206797
Spiess, Birgit: Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials / Birgit Spiess, Sébastien Rinaldetti, Nicole Naumann, Norbert Galuschek, Ute Kossak-Roth, Patrick Wuc… , March 21, 2019. - 15 S. : Diagramme
In: PLOS ONE, ISSN 1932-6203. 14(2019,3) Artikel-Nummer e0214305, Seite 1-15, 15 Seiten
DOI: 10.1371/journal.pone.0214305
Saußele, Susanne: Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI) : a prespecified interim analysis of a prospective, multicentre, non-randomised, trial / Susanne Saussele, Johan Richter, Joelle Guilhot, Franz X Gruber, Henrik Hjorth-Hansen, Antonio Almei… , May 4, 2018. - 11 S.
In: The lancet, ISSN 1474-5488. 19(2018), 6, Seite 747-757
DOI: 10.1016/S1470-2045(18)30192-X
Saußele, Susanne: Defining therapy goals for major molecular remission in chronic myeloid leukemia : results of the randomized CML Study IV / Susanne Saussele, Rüdiger Hehlmann, Alice Fabarius, Sabine Jeromin, Ulrike Proetel, Sebastien Rinald… , 26 February 2018. - 7 S.
In: Leukemia, ISSN 1476-5551. 32(2018), 5, Seite 1222-1228
DOI: 10.1038/s41375-018-0055-7
Ross, David M.: Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib : 96-week update of the ENESTfreedom study / David M. Ross, Tamas Masszi, María Teresa Gómez Casares, Andrzej Hellmann, Jesper Stentoft, Eibhlin … , 22 February 2018. - 10 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 144(2018), 5, Seite 945-954
DOI: 10.1007/s00432-018-2604-x
Inselmann, Sabrina: Development, function, and clinical significance of plasmacytoid dendritic cells in chronic myeloid leukemia / Sabrina Inselmann, Ying Wang, Susanne Saussele, Lea Fritz, Christin Schütz, Magdalena Huber, Simone … , August 30, 2018. - 13 S.
In: Cancer research, ISSN 1538-7445. 78(2018), 21, Seite 6223-6234
DOI: 10.1158/0008-5472.CAN-18-1477
Rinaldetti, Sébastien: Effect of ABCG2, OCT1, and ABCB1 (MDR1) gene expression on treatment-free remission in a EURO-SKI subtrial / Sébastien Rinaldetti, Markus Pfirrmann, Kirsi Manz, Joelle Guilhot, Christian Dietz, Panayiotidis Pa… , 8 February 2018. - 6 S.
In: Clinical lymphoma & myeloma, ISSN 1938-0712. 18(2018), 4, Seite 266-271
DOI: 10.1016/j.clml.2018.02.004
Kim, Dong Wook: Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase : the DASPERSE study / Dong-Wook Kim, Susanne Saussele, Loretta A. Williams, Hesham Mohamed, Yuanxin Rong, Teresa Zyczynski… , 20 March 2018. - 11 S.
In: Annals of hematology, ISSN 1432-0584. 97(2018), 8, Seite 1357-1367
DOI: 10.1007/s00277-018-3295-8
Mughal, Tariq I.: Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms / Tariq I. Mughal, Jason Gotlib, Ruben Mesa, Steffen Koschmieder, H. Jean Khoury, Jorge E. Cortes, Tiz… , 14 February 2018. - 8 S.
In: Leukemia research, ISSN 1873-5835. 67(2018), Seite 67-74
DOI: 10.1016/j.leukres.2018.02.008
Bouillon, Anne-Sophie: Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia / Anne-Sophie Bouillon, Monica S. Ventura Ferreira, Shady Adnan Awad, Johan Richter, Andreas Hochhaus,… , July 6, 2018. - 8 S.
In: Blood advances, ISSN 2473-9537. 2(2018), 13, Seite 1572-1579
DOI: 10.1182/bloodadvances.2018017772
Spiess, Birgit: The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia / Birgit Spiess, Nicole Naumann, Norbert Galuschek, Sébastien Rinaldetti, Ute Kossak-Roth, Irina Tarno… , April 24, 2018. - 12 S.
In: PLOS ONE, ISSN 1932-6203. 13(2018,4) Artikel-Nummer e0196326, 12 Seiten
DOI: 10.1371/journal.pone.0196326
Ilander, Mette Matilda: Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia / M. Ilander, U. Olsson-Strömberg, H. Schlums, J. Guilhot, O. Brück, H. Lähteenmäki, T. Kasanen, P. Ko… , 2017. - 9 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 5, Seite 1108-1116
DOI: 10.1038/leu.2016.360
Pfirrmann, Markus: No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival : results in 1494 patients with chronic myeloid leukemia treated with imatinib / Markus Pfirrmann, Dobromira Evtimova, Susanne Saussele, Fausto Castagnetti, Francisco Cervantes, Jer… , 12 January 2017. - 8 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 143(2017), 5, Seite 843-850
DOI: 10.1007/s00432-016-2321-2
Saußele, Susanne: Therapie der chronischen myeloischen Leukämie mit Imatinib : Iris-Studie / S. Saußele, S. Nitschmann, 19. September 2017. - 2 S.
In: Der Internist, ISSN 1432-1289. 58(2017), 11, Seite 1220-1221
DOI: 10.1007/s00108-017-0322-0
Hoffmann, Verena Sophia: Treatment and outcome of 2904 CML patients from the EUTOS population-based registry / VS Hoffmann, M Baccarani, J Hasford, F Castagnetti, F Di Raimondo, LF Casado, A Turkina, D Zackova, … , 2017. - 9 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 3, Seite 593-601
DOI: 10.1038/leu.2016.246
Giles, Francis J.: Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase : ENEST1st subanalysis / Francis J. Giles, Delphine Rea, Gianantonio Rosti, Nicholas C.P. Cross, Juan Luis Steegmann, Laimona… , 31 March 2017. - 12 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 143(2017), 8, Seite 1585-1596
DOI: 10.1007/s00432-017-2402-x
Hehlmann, Rüdiger: Assessment of imatinib as first-line treatment of chronic myeloid leukemia : 10-year survival results of the randomized CML study IV and impact of non-CML determinants / R. Hehlmann, M. Lauseker, S. Saußele, M. Pfirrmann, S. Krause, H.J. Kolb, A. Neubauer, D.K. Hossfeld… , 2017. - 9 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 11, Seite 2398-2406
DOI: 10.1038/leu.2017.253
Lauseker, Michael: Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death / Michael Lauseker, PhD, Joerg Hasford, MD, Susanne Saussele, MD, Stephan Kremers, MD, Doris Kraemer, … , February 13, 2017. - 5 S.
In: Cancer, ISSN 1097-0142. 123(2017), 13, Seite 2467-2471
DOI: 10.1002/cncr.30636
Hochhaus, Andreas: Chronic myeloid leukaemia : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up / A. Hochhaus, S. Saussele, G. Rosti, F.-X. Mahon, J.J.W.M. Janssen, H. Hjorth-Hansen, J. Richter and … , 13 July 2017. - 11 S.
In: Annals of oncology, ISSN 1569-8041. 28(2017), Supplement 4, Seite iv41-iv51
DOI: 10.1093/annonc/mdx219
Hochhaus, Andreas: Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase : results from the ENESTfreedom study / A. Hochhaus, T. Masszi, F.J. Giles, J.P. Radich, D.M. Ross, M.T. Gómez Casares, A. Hellmann, J. Sten… , 20 February 2017. - 7 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 7, Seite 1525-1531
DOI: 10.1038/leu.2017.63
Schütz, Christian: Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML / C. Schütz, S. Inselmann, S. Sausslele, C.T. Dietz, M.C. Müller, E. Eigendorff, C.A. Brendel, S.K. Me… , 27 January 2017. - 8 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 4, Seite 829-836
DOI: 10.1038/leu.2017.9
Barreto Miranda, Manuel: Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment : long-term observation in CML Study IV / M.B. Miranda, M. Lauseker, M.-P. Kraus, U. Proetel, B. Hanfstein, A. Fabarius, G.M. Baerlocher, D. H… , 26 February 2016. - 8 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 6, Seite 1255-1262
DOI: 10.1038/leu.2016.20
Steegmann, Juan Luis: European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia / J.L. Steegmann, M. Baccarani, M. Breccia, L.F. Casado, V. García-Gutiérrez, A. Hochhaus, D.-W. Kim, … , 3 June 2016. - 24 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 8, Seite 1648-1671
DOI: 10.1038/leu.2016.104
Saußele, Susanne: The concept of treatment-free remission in chronic myeloid leukemia / S. Saußele, J. Richter, A. Hochhaus and F.-X. Mahon, 3 June 2016. - 10 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 8, Seite 1638-1647
DOI: 10.1038/leu.2016.115
Hehlmann, Rüdiger: Management of CML-blast crisis / Rüdiger Hehlmann, Susanne Saußele, Astghik Voskanyan, Richard T. Silver, September 2016. - 13 S.
In: Best practice & research, ISSN 1532-1924. 29(2016), 3, Seite 295-307
DOI: 10.1016/j.beha.2016.10.005
Kossak-Roth, Ute: Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL) / Ute Kossak-Roth, Susanne Saußele, Carlo Aul, Thomas Büchner, Hartmut Döhner, Martin Dugas, Gerhard E… , 15. März 2016. - 10 S.
In: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, ISSN 1437-1588. 59(2016), 4, Seite 444-453
DOI: 10.1007/s00103-016-2315-x
Padula, William V.: Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in chronic phase after generic entry of imatinib in the United States / William V. Padula, Richard A. Larson, Stacie B. Dusetzina, Jane F. Apperley, Rudiger Hehlmann, Miche… , 4 March 2016. - 9 S.
In: Journal of the National Cancer Institute, ISSN 1460-2105. 108(2016,7) Artikel-Nummer djw003, 9 Seiten
DOI: 10.1093/jnci/djw003
Gratwohl, Alois: Long-term outcome of patients with newly diagnosed chronic myeloid leukemia : a randomized comparison of stem cell transplantation with drug treatment / A. Gratwohl, M. Pfirrmann, A. Zander, N. Kröger, D. Beelen, J. Novotny, C. Nerl, C. Scheid, K. Spiek… , 2016. - 8 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 3, Seite 562-569
DOI: 10.1038/leu.2015.281
Pfirrmann, Markus: Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia / M. Pfirrmann, M. Baccarani, S. Saussele, J. Guilhot, F. Cervantes, G. Ossenkoppele, V.S. Hoffmann, F… , 2016. - 9 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 1, Seite 48-56
DOI: 10.1038/leu.2015.261
Burchert, Andreas: Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia / A. Burchert, S. Saussele, E. Eigendorff, M.C. Müller, K. Sohlbach, S. Inselmann, C. Schütz, S.K. Met… , 25 February 2015. - 5 S.
In: Leukemia, ISSN 1476-5551. 29(2015), 6, Seite 1331-1335
DOI: 10.1038/leu.2015.45
Saußele, Susanne: Management of chronic myeloid leukemia in blast crisis / S. Saußele, Richard T. Silver, April 2015. - 7 S.
In: Annals of hematology, ISSN 1432-0584. 94(2015), Supplement 2, Seite S159-S165
DOI: 10.1007/s00277-015-2324-0
Saußele, Susanne: Impact of comorbidities on overall survival in patients with chronic myeloid leukemia : results of the randomized CML Study IV / Susanne Saußele, Marie-Paloma Krauß, Rüdiger Hehlmann, Michael Lauseker, Ulrike Proetel, Lida Kalman… , 2 July 2015. - 8 S.
In: Blood, ISSN 1528-0020. 126(2015), 1, Seite 42-49
DOI: 10.1182/blood-2015-01-617993
Kiani, Alexander: Prävention und Management kardiovaskulärer Erkrankungen mit Nilotinib : Empfehlungen einer interdisziplinären Expertengruppe / A. Kiani, P. Kuhlencordt, A. Hochhaus, H. Tesch, S. Saussele, P. Le Coutre, August 2015. - 8 S.
In: Der Onkologe, ISSN 1433-0415. 21(2015), 8, Seite 724-731
DOI: 10.1007/s00761-015-2990-5
Fabarius, Alice: Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML / Alice Fabarius, Lida Kalmanti, Christian T. Dietz, Michael Lauseker, Sébastien Rinaldetti, Claudia H… , December 2015. - 10 S.
In: Annals of hematology, ISSN 1432-0584. 94(2015), 12, Seite 2015-2024
DOI: 10.1007/s00277-015-2494-9
Kalmanti, Lida: Safety and efficacy of imatinib in CML over a period of 10 years : data from the randomized CML-study IV / L. Kalmanti, S. Saussele, M. Lauseker, M.C. Müller, C.T. Dietz, L. Heinrich, B. Hanfstein, U. Proete… , May 2015. - 10 S.
In: Leukemia, ISSN 1476-5551. 29(2015), 5, Seite 1123-1132
DOI: 10.1038/leu.2015.36
Efficace, Fabio: International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients : the EORTC QLQ-CML24 / Fabio Efficace, Michele Baccarani, Massimo Breccia, Susanne Saussele, Gregory Abel, Giovanni Caocci,… , April 2014. - 12 S.
In: Quality of life research, ISSN 1573-2649. 23(2014), 3, Seite 825-836
DOI: 10.1007/s11136-013-0523-5
Proetel, Ulrike: Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients : a subanalysis of the randomized CML-Study IV / Ulrike Proetel, Nadine Pletsch, Michael Lauseker, Martin C. Müller, Benjamin Hanfstein, Stefan W. Kr… , 2014. - 10 S.
In: Annals of hematology, ISSN 1432-0584. 93(2014), 7, Seite 1167-1176
DOI: 10.1007/s00277-014-2041-0
Agrawal, Mridul: MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure / Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha,… , 2014. - 8 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 7, Seite 1478-1485
DOI: 10.1038/leu.2014.6
Pfirrmann, Markus: Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia / Pfirrmann, Markus; Saussele, Susanne; Hochhaus, Andreas; Reiter, Andreas; Berger, Ute; Hossfeld, Die… , 2014. - 15 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 140(2014), 8, Seite 1367-1381
DOI: 10.1007/s00432-014-1662-y
Saußele, Susanne: Allogeneic hematopoietic stem cell transplantation (HSCT) in the Imatinib-era : update on the survival outcome following allogeneic HSCT after Imatinib failure : results of the german CML study IV / Susanne Saussele, Michael Lauseker, Martin C. Müller, Alois Gratwohl, Dietrich Beelen, Donald W. Bun… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014), 21
Saußele, Susanne: Defining therapy goals for major molecular remission in chronic myeloid leukemia : results of the randomized CML-study IV / Susanne Saussele, Rüdiger Hehlmann, Christian Dietz, Susanne Schnittger, Alice Charlotte Fabarius, L… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 69967, 1 S.
Richter, Johan: Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib : a tyrosine kinase inhibitor withdrawal syndrome? / Richter, Johan ... Saussele, Susanne ..., 2014. - 3 S.
In: Journal of clinical oncology, ISSN 1527-7755. 32(2014), 25, Seite 2821-2823
DOI: 10.1200/JCO.2014.55.6910
Mahon, François-Xavier: Interim analysis of a Pan European stop tyrosine kinase inhibitor trial in chronic myeloid leukemia : the EURO-SKI study / Francois-Xavier Mahon, Johan Richter, Joelle Guilhot, Martin C. Muller, Christian Dietz, Kimmo Porkk… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 74060, 1 S.
Ilander, Mette Matilda: Early disease relapse after tyrosine kinase inhibitor treatment discontinuation in CML is related both to low number and impaired function of NK-Cells / Mette Matilda Ilander, Ulla Olsson-Strömberg, Hanna Lähteenmäki, Kasanen Tiina, Perttu Koskenvesa, S… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 66989, 1 S.
Hanfstein, Benjamin: Comparing the prognostic significance of early predictors of survival in chronic myeloid leukemia (CML) treated with imatinib : an analysis of the randomized CML-study IV / Benjamin Hanfstein, Michael Lauseker, Rüdiger Hehlmann, Susanne Saussele, Philipp Erben, Christian D… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 70540, 1 S.
Hehlmann, Rüdiger: Complete cytogenetic response, not deep molecular response, is associated with survival in chronic myeloid leukemia reply / Hehlmann, Ruediger ... Saussele, Susanne ..., 2014. - 2 S.
In: Journal of clinical oncology, ISSN 1527-7755. 32(2014), 27, Seite 3078-3079
DOI: 10.1200/JCO.2014.56.3908
Hanfstein, Benjamin: A two-fold rise of BCR-ABL transcript levels advises BCR-ABL mutation analysis in imatinib-treated chronic myeloid leukemia (CML) : an analysis of the randomized CML-study IV / Benjamin Hanfstein, Niklas Westhoff, Rüdiger Hehlmann, Susanne Saussele, Michael Lauseker, Thomas Er… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 3138, 1 S.
Hanfstein, Benjamin: Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib / Hanfstein, Benjamin ... Hehlmann, Ruediger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fab… , 2014. - 7 S.
In: Haematologica, ISSN 1592-8721. 99d(2014), 9, Seite 1441-1447
DOI: 10.3324/haematol.2013.096537
Dietz, Christian: Prognostic value of multi-drug resistance 1 gene ( MDR1) expression in newly diagnosed patients with chronic myeloid leukemia on nilotinib treatment : a subanalysis of the ENEST1st study / Christian Dietz, Michael Lauseker, Benjamin Hanfstein, Philippe Rousselot, Thoralf Lange, Jacqueline… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 3144, 1 S.
Hehlmann, Rüdiger: Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib : results from the randomized CML-study IV / Hehlmann, Rüdiger; Müller, Martin C.; Lauseker, Michael; Hanfstein, Benjamin; Fabarius, Alice; Schre… , 2014. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 32(2014), 5, Seite 415-423
DOI: 10.1200/JCO.2013.49.9020
Hanfstein, Benjamin: Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib / Hanfstein, B.; Shlyakhto, V. ... Hehlmann, R.; Saussele, S.; Dietz, C.; Erben, P.; Fabarius, A.; Pro… , 2014. - 5 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 10, Seite 1988-1992
DOI: 10.1038/leu.2014.153
Lauseker, Michael: Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase / Lauseker, Michael; Hanfstein, Benjamin ... Fabarius, Alice ... Saussele, Susanne; Dietz, Christian T… , 2014. - 5 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 140(2014), 11, Seite 1965-1969
DOI: 10.1007/s00432-014-1746-8
Kalmanti, Lida: Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators : results from the randomized CML study IV / Lida Kalmanti, Susanne Saussele, Michael Lauseker, Ulrike Proetel, Martin C. Müller, Benjamin Hanfst… , 2014. - 10 S.
In: Annals of hematology, ISSN 1432-0584. 93(2014), 1, Seite 71-80
DOI: 10.1007/s00277-013-1937-4
Baccarani, Michele: European LeukemiaNet recommendations for the management of chronic myeloid leukemia : 2013 / Baccarani, Michele ... Mueller, Martin C. ... Saussele, Susanne ... Hehlmann, Ruediger, 2013. - 13 S.
In: Blood, ISSN 1528-0020. 122(2013), 6, Seite 872-884
DOI: 10.1182/blood-2013-05-501569
Saußele, Susanne: Therapieoptimierung am Beispiel der chronischen myeloischen Leukämie durch nationale und internationale Kooperation / vorgelegt von Susanne Saußele, 2013. - 88 Bl. : Ill., graph. Darst.
La Rosée, Paul: Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib / La Rosee, Paul ... Mueller, Martin C.; Erben, Philipp ... Saussele, Susanne ..., 2013. - 6 S.
In: Annals of hematology, ISSN 0939-5555. 92(2013), 10, Seite 1345-1350
Ihrig, Kristina: Focus on academic multicenter trials : impact of the german drug law on hematological/oncological therapy optimization trials / Ihrig, Kristina ... Saussele, Susanne ..., 2013. - 6 S.
In: Onkologie, ISSN 0378-584X. 36(2013), 2, Suppl., Seite 23-28
Efficace, Fabio: Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? : GIMEMA and EORTC Quality of Life Group / Fabio Efficace, Massimo Breccia, Susanne Saussele, Ute Kossak-Roth, Annarita Cardoni, Giovanni Caocc… , 29 April 2012. - 11 S.
In: Annals of hematology, ISSN 1432-0584. 91(2012), 9, Seite 1371-1381
DOI: 10.1007/s00277-012-1458-6
Saußele, Susanne: Clinical trials in chronic myeloid leukemia / Susanne Saussele, Markus Pfirrmann, 16 March 2012. - 7 S.
In: Current hematologic malignancy reports, ISSN 1558-822X. 7(2012), 2, Seite 109-115
DOI: 10.1007/s11899-012-0118-1
Hoffmann, Verena Sophia: The EUTOS CML score aims to support clinical decision-making / Verena Hoffmann, Michele Baccarani, Joerg Hasford, Joelle Guilhot, Susanne Saussele, Gianantonio Ros… , 2012. - 2 S.
In: Blood, ISSN 1528-0020. 119(2012), 12, Seite 2966-2967
DOI: 10.1182/blood-2012-01-402511
Guilhot, Joëlle: Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia : a proposal by the European LeukemiaNet / Joëlle Guilhot, Michele Baccarani, Richard E. Clark, Francisco Cervantes, François Guilhot, Andreas … , April 16, 2012. - 9 S.
In: Blood, ISSN 1528-0020. 119(2012), 25, Seite 5963-5971
DOI: 10.1182/blood-2011-10-383711
Nowak, Daniel: SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3 / Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, Maximilian Mossner, Florian Nolte, Verena Nowa… , 9 April 2012. - 12 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 51(2012), 8, Seite 756-767
DOI: 10.1002/gcc.21961
Hanfstein, Benjamin: Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) / B Hanfstein, MCMü̈ller, R Hehlmann, P Erben, M Lauseker, A Fabarius, S Schnittger, C Haferlach, G Gö… , 24 April 2012. - 7 S.
In: Leukemia, ISSN 1476-5551. 26(2012), 9, Seite 2096-2102
DOI: 10.1038/leu.2012.85
Pfirrmann, Markus: Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia / M. Pfirrmann, A. Hochhaus, M. Lauseker, S. Saußele, R. Hehlmann and J. Hasford, 20 May 2011. - 6 S.
In: Leukemia, ISSN 1476-5551. 25(2011), 9, Seite 1433-1438
DOI: 10.1038/leu.2011.116
Hehlmann, Rüdiger: Treatment of chronic myeloid leukemia when imatinib fails / Rüdiger Hehlmann, Susanne Jung-Munkwitz, Susanne Saußele, 13 Jan 2011. - 15 S.
In: Expert opinion on pharmacotherapy, ISSN 1744-7666. 12(2011), 2 vom: Jan., Seite 269-283
DOI: 10.1517/14656566.2011.533169
Hehlmann, Rüdiger: The European LeukemiaNet : achievements and perspectives / Rüdiger Hehlmann, David Grimwade, Bengt Simonsson, Jane Apperley, Michele Baccarani, Tiziano Barbui,… , [January, 2011]. - 7 S. : 1 Karte
In: Haematologica, the hematology journal, ISSN 1592-8721. 96(2011), 1 vom: Jan., Seite 156-162
DOI: 10.3324/haematol.2010.032979
Hasford, Joerg: Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment : the EUTOS score / Joerg Hasford, Michele Baccarani, Verena Hoffmann, Joelle Guilhot, Susanne Saussele, Gianantonio Ros… , [2011]. - 7 S. : Diagramme
In: Blood, ISSN 1528-0020. 118(2011), 3, Seite 686-692
DOI: 10.1182/blood-2010-12-319038
Hehlmann, Rüdiger: Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia / Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine P… , March 21, 2011. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 29(2011), 12, Seite 1634-1642
DOI: 10.1200/JCO.2010.32.0598
Hehlmann, Rüdiger: Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia / Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine P… , 2011. - 9 S.
In: Journal of clinical oncology, ISSN 0732-183X. 29(2011), 12 vom: 20. Apr., Seite 1634-1642
Fabarius, Alice: Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML : long-term observation of 1151 patients from the randomized CML Study IV / Alice Fabarius, Armin Leitner, Andreas Hochhaus, Martin C. Müller, Benjamin Hanfstein, Claudia Hafer… , December 22, 2011. - 9 S.
In: Blood, ISSN 1528-0020. 118(2011), 26, Seite 6760-6768
DOI: 10.1182/blood-2011-08-373902
Saußele, Susanne: Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors / S. Saußele, R. Hehlmann, A. Gratwohl and A. Hochhaus, 2012. - 1 S.
In: Bone marrow transplantation, ISSN 1476-5365. 47(2012), 2, Seite 304
DOI: 10.1038/bmt.2011.70
Saußele, Susanne: Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era : evaluation of its impact within a subgroup of the randomized German CML Study IV / Susanne Saussele, Michael Lauseker, Alois Gratwohl, Dietrich W. Beelen, Donald Bunjes, Rainer Schwer… , March 11, 2010. - 6 S.
In: Blood, ISSN 1528-0020. 115(2010), 10, Seite 1880-1885
DOI: 10.1182/blood-2009-08-237115
Saußele, Susanne: Klinische Forschung im „European LeukemiaNet” / S. Saußele, K. Adam, A. Hochhaus, M.C. Béné, T. Büchner, A. Burnett, G. Finazzi, C. Fonatsch, E. Glu… , 20. Oktober 2006. - 4 S.
In: Deutsche medizinische Wochenschrift, ISSN 1439-4413. 131(2006), 43, Seite 2423-2426
DOI: 10.1055/s-2006-955027
Saußele, Susanne: Klinische Forschung im Kompetenznetz „Akute und chronische Leukämien“ / Susanne Saußele, Ute Berger, Carlo Aul, Thomas Büchner, Hartmut Döhner, Gerhard Ehninger, Arnold Gan… , May 2006. - 7 S.
In: Medizinische Klinik, ISSN 1615-6722. 101(2006), 5, Seite 414-420
DOI: 10.1007/s00063-006-1056-2
Gnad-Vogt, Ulrike: Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer : results of a phase II trial / Senta Ulrike Gnad-Vogt, Ralf-Dieter Hofheinz, Susanne Saussele, Sebastian Kreil, Andreas Willer, Fra… , April 2005. - 6 S.
In: Anti-cancer drugs, ISSN 1473-5741. 16(2005), 4, Seite 435-440
Hofheinz, Ralf-Dieter: Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer : a phase II study / Ralf-Dieter Hofheinz, Ulrike Gnad-Vogt, Axel Wein, Susanne Saussele, Sebastian Kreil, Lothar Pilz, R… , 2005. - 7 S.
In: Anti-cancer drugs, ISSN 1473-5741. 16(2005), 1, Seite 39-45
Lengfelder, Eva: Treatment concepts of acute promyelocytic leukemia / Eva Lengfelder, Susanne Saussele, Andreas Weisser, Thomas Büchner, Rüdiger Hehlmann, 19 October 2005. - 14 S.
In: Critical reviews in oncology, hematology, ISSN 1879-0461. 56(2005), 2, Seite 261-274
DOI: 10.1016/j.critrevonc.2004.08.009
Berger, Ute: Die Netzwerkzentrale des Kompetenznetzes "Akute und chronische Leukämien" / U. Berger, O. Maywald, S. Saußele, M. Schatz, M. Hummel, A. Hochhaus, R. Hehlmann, 2004. - 3 S.
In: Die medizinische Welt, ISSN 0025-8512. 55(2004), Seite 249-251
Hofheinz, Ralf-Dieter: Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer : results of an extended multicentre phase-I trial / R.-D. Hofheinz, J.T. Hartmann, A. Willer, K. Oechsle, G. Hartung, U. Gnad, S. Saussele, S. Kreil, C.… , 06 July 2004. - 5 S.
In: British journal of cancer, ISSN 1532-1827. 91(2004), 5, Seite 834-838
DOI: 10.1038/sj.bjc.6602025
Hofheinz, Ralf-Dieter: Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer / R.-D. Hofheinz, A. Willer, A. Weisser, U. Gnad, S. Saussele, S. Kreil, J.T. Hartmann, R. Hehlmann an… , 13 April 2004. - 5 S.
In: British journal of cancer, ISSN 1532-1827. 90(2004), 10, Seite 1893-1897
DOI: 10.1038/sj.bjc.6601786
Reiter, Andreas: Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia / Andreas Reiter, Susanne Sauβele, David Grimwade, Joseph L. Wiemels, Mark R. Segal, Marina Lafage-Poc… , 2003. - 14 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 36(2003), 2, Seite 175-188
DOI: 10.1002/gcc.10154
Hochhaus, Andreas: Monitoring of residual disease in patients with chronic myelogenous leukemia using specific fluorescent hybridization probes for real-time quantitative RT-PCR / Andreas Hochhaus, Michael Emig, Andreas Weisser, Susanne Saussele, Martin Müller, Paul La Rosée, Ch… , 2001. - 15 S.
In: Rapid Cycle Real-Time PCR. (2001), Seite 171-185
DOI: 10.1007/978-3-642-59524-0_20
Hochhaus, Andreas: Detection and quantification of residual disease in chronic myelogenous leukemia / A. Hochhaus, A. Weisser, P. La Rosée, M. Emig, M.C. Müller, S. Saußele, A. Reiter, C. Kuhn, U. Berge… , 06 June 2000. - 8 S.
In: Leukemia, ISSN 1476-5551. 14(2000), 6, Seite 998-1005
DOI: 10.1038/sj.leu.2401811
Hochhaus, Andreas: Molecular heterogeneity in complete cytogenetic responders after interferon-α therapy for chronic myelogenous leukemia : low levels of minimal residual disease are associated with continuing remission / Andreas Hochhaus, Andreas Reiter, Susanne Saußele, Anja Reichert, Michael Emig, Jaspal Kaeda, Beate … , January 1, 2000. - 5 S.
In: Blood, ISSN 1528-0020. 95(2000), 1, Seite 62-66
DOI: 10.1182/blood.V95.1.62
Lengfelder, Eva: Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid : effects in patients with newly diagnosed acute promyelocytic leukemia / E. Lengfelder, A. Reichert, C. Schoch, D. Haase, T. Haferlach, H. Löffler, P. Staib, A. Heyll, W. Se… , 04 August 2000. - 9 S.
In: Leukemia, ISSN 1476-5551. 14(2000), 8, Seite 1362-1370
DOI: 10.1038/sj.leu.2401843
Saußele, Susanne: Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes / S Saußele, A Weißer, MC Müller, M Emig, P La Rosée, P Paschka, C Kuhn, A Willer R. Hehlmann and A Ho… , 02 November 2000. - 5 S.
In: Leukemia, ISSN 1476-5551. 14(2000), 11, Seite 2006-2010
DOI: 10.1038/sj.leu.2401929
Emig, Michael: Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR / M. Emig, S. Saußele, H. Wittor, A. Weißer, A. Reiter, A. Willer, U. Berger, R. Hehlmann, N.C.P. Cros… , 03 November 1999. - 8 S.
In: Leukemia, ISSN 1476-5551. 13(1999), 11, Seite 1825-1832
DOI: 10.1038/sj.leu.2401566
Saußele, Susanne: Transkriptionsmuster HERV-K-verwandter Sequenzen in menschlichen Tumorgeweben / vorgelegt von Susanne Saußele, 1997. - V, 80 Bl : Ill., graph. Darst

IDs

GND:

115839860

Links

Saußele, Susanne in ...

Export publication list

heiBIB

Please contact biblio@ub.uni-heidelberg.de in case of any errors or omissions.

Information concerning heiBIB (including embedding the publication list in existing websites).

Impressum / Datenschutz Design